rss
J Med Genet 2006;43:232-237 doi:10.1136/jmg.2004.029173
  • Short report

Ehlers-Danlos syndrome and periventricular nodular heterotopia in a Spanish family with a single FLNA mutation

  1. P Gómez-Garre1,*,
  2. M Seijo2,*,
  3. E Gutiérrez-Delicado1,*,
  4. M Castro del Río2,
  5. C de la Torre3,
  6. C Gómez-Abad1,
  7. J Morales-Corraliza1,
  8. M Puig4,
  9. J M Serratosa1
  1. 1Laboratorio de Neurología, Fundación Jiménez Díaz, Madrid, Spain
  2. 2Servicio de Neurología, Complexo Hospitalario de Pontevedra, Pontevedra, Spain
  3. 3Servicio de Dermatología, Complexo Hospitalario de Pontevedra
  4. 4Servicio de Radiología, Complexo Hospitalario de Pontevedra
  1. Correspondence to:
 Dr José M Serratosa
 Unidad de Epilepsia, Laboratorio de Neurología, Fundación Jiménez Díaz, Avda Reyes Católicos 2, 28040 Madrid, Spain; serratosa{at}telefonica.net
  • Received 16 November 2004
  • Accepted 27 June 2005
  • Revised 24 June 2005
  • Published Online First 1 July 2005

Abstract

Background: The Ehlers-Danlos syndrome (EDS) comprises a group of hereditary connective tissue disorders. Periventricular nodular heterotopia (PNH) is a human neuronal migration disorder characterised by seizures and conglomerates of neural cells around the lateral ventricles of the brain, caused by FLNA mutations. FLNA encodes filamin A, an actin binding protein involved in cytoskeletal organisation. The amino-terminal actin binding domain (ABD) of filamins contains two tandem calponin homology domains, CHD1 and CHD2.

Objective: To report clinical and genetic analyses in a Spanish family affected by a connective tissue disorder suggestive of EDS type III and PNH.

Methods: A clinical and molecular study was undertaken in the three affected women. Clinical histories, physical and neurological examinations, brain magnetic resonance imaging studies, and skin biopsies were done. Genetic analysis of the FLNA gene was undertaken by direct sequencing and restriction fragment length polymorphism analysis.

Results: Mutation analysis of the FLNA gene resulted in the identification of a novel mutation in exon 3 (c.383C→T) segregating with the combination of both syndromes. This mutation results in a substitution of an alanine residue (A128V) in CHD1.

Conclusions: The findings suggest that the Ala128Val mutation causes the dual EDS-PNH phenotype. This association constitutes a new variant within the EDS spectrum. This is the first description of a familial EDS-PNH association with a mutation in FLNA.

Footnotes

  • * These authors contributed equally to this work

  • Published Online First 1 July 2005

  • Conflicts of interest: none declared

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.